MedTrace Logo

Growth, Tolerance in Healthy Infants Fed a Partially Hydrolyzed Rice Protein

NCT00997971 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2009-10-20

No results posted yet for this study

Summary

The purpose of this study is to assess growth and global tolerance in healthy new born infants with minor gastrointestinal troubles and/or allergic risk, fed an experimental partially hydrolyzed rice protein infant formula.

Conditions

  • Growth
  • Allergy

Interventions

OTHER

Modilac Rose 1

Infant formula used for non-breastfed children

Sponsors & Collaborators

  • Sodilac

    lead INDUSTRY

Principal Investigators

  • Jean-Philippe Girardet, PhD · Hôpital d'enfants Armand Trousseau

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
1 Month
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00997971 on ClinicalTrials.gov